CERIBELL, INC reports a Return on Equity (ROE) of -42.87%.

What is CBLL's dividend yield?

CERIBELL, INC offers a dividend yield of 0.00%.

What is CBLL's Quality Score?

Our AI rates CBLL's overall financial quality at 0 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CBLL?

Our AI Timing Score for CBLL is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CBLL belong to?

CERIBELL, INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

CBLL (NASDAQ) Stock Analysis | CERIBELL, INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

CBLL AI Analysis Summary

Our AI summary for CBLL: CERIBELL, INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -42.87%, a dividend yield of 0.00%. Its financial Quality Score stands at 0/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CBLL

CERIBELL, INC

US:NASDAQ STOCK Healthcare >> Medical Devices News 90

USD 17.69

0.05 (0.28%) Day Change

Watchlist Portfolio Compare Chart

0.15

D/E

-42.9%

ROE

-33.9%

ROA

0.00%

Div Yield

CERIBELL, INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 17.69 Price 0.05 (0.28%) Day Change	NEWS SCORE: 90

CBLL, the overall quality is not good ( Quality = 0) and the timing to buy is ...(Sign In to See)...

Loading chart...

0 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	17.69
PBV / Sector	4.75 / -101.57
Earning Per Share	-1.60

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	6.21 M
Average 1W Daily Value	6.41 M

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-63.51 / 20.50
NPM Average (%) / Sector	-78.76 / -15.37
NPM Change Average (%) / Sector	-14.19 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-33.90 / 39.11
ROA Average (%) / Sector	-34.42 / 5.58
ROA Change Average (%) / Sector	7.12 / 104.50
ROE (%) / Sector	-42.87 / -166.42
ROE Average (%) / Sector	-5.83 / -16.93
ROE Change Average (%) / Sector	-33.11 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 07:59:37
Symbol	CBLL
Name	CERIBELL, INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	37.94 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	669.31 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 360 North Pastoria Avenue, Sunnyvale, CA, United States, 94085

Phone: 800 436 0826

Website: https://www.ceribell.com

Employees: 327

Sector: Healthcare >> Medical Devices

Description: CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.